Blog Posts

340B Provider Advocates Slam CBO Report on 340B Growth and Budgetary Impact, Drug Industry Touts Findings

340B provider advocates have criticized findings in the CBO's recent report on the 340B program.
340B program advocates recently took aim at a new Republican-requested Congressional Budget Office (CBO) report on the 340B program, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

After 340B ACCESS Act’s Reintroduction, Critics Speak Out While Original Supporters Hold Back

The recently reintroduced 340B ACCESS Act has garnered criticism from a range of 340B provider groups, including one that supported last year's bill.
A controversial GOP-backed plan to overhaul the 340B program continued to draw pushback from provider advocates—as well as muted or [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

FQHCs Face Unique Challenges—Strong Partnerships Can Make All the Difference

SPONSORED CONTENT

Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. However, they are facing mounting challenges that threaten their ability to maintain operations and meet growing community needs. With limited infrastructure, evolving regulations, upcoming Medicaid cuts, drops in the insured

Read More »

Hospitals File Emergency Appeal to Block J&J’s 340B Audits in Federal Court

Multiple hospitals filed an emergency motion asking the D.C. Circuit Court of Appeals to block J&J's HRSA-approved 340B audit requests.
Four major hospitals recently filed an emergency appeal to block Johnson & Johnson (J&J) from auditing their 340B programs—three months [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Exempts Maine and Oregon from 340B Contract Pharmacy Restrictions

GSK will loosen its contract pharmacy restrictions for Maine and Oregon covered entities in late September.
A U.K.-based drugmaker recently announced it will soon exempt covered entities in two additional states from its 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Federal Appeals Court Unanimously Upholds Mississippi’s 340B Contract Pharmacy Access Law Against AbbVie Challenge

The U.S. 5th Circuit Court of Appeals affirmed a lower court's ruling denying AbbVie's bid to block enforcement of Mississippi's 340B contract pharmacy access law.
A federal appeals court today unanimously upheld Mississippi’s 340B contract pharmacy access law, rejecting AbbVie’s bid to block enforcement of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Publishes More Stakeholder Comments on Controversial 340B Rebate Pilot Proposal

HRSA has published 1,116 of the 1,243 comments it received on its controversial proposed 340B rebate pilot.
The Health Resources and Services Administration (HRSA) has now published 1,116 of the 1,243 comments it received on its controversial [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Appeals Court Hears Arguments in Texas Hospitals’ Lawsuit Challenging DSH Calculation Changes

The 5th Circuit Court of Appeals recently heard arguments in a case, which a group of Texas hospitals filed challenging an HHS rule used to help calculate hospitals’ 340B eligibility.
A federal appeals court recently heard arguments in a case, which a group of Texas hospitals filed challenging a Department [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Resolving Negative Accumulations in a Virtual Inventory: What Would You Do?

SPONSORED CONTENT

Consider the following scenario: A recent change in electronic health record billing at one of your outpatient clinics has led to accumulation errors in your 340B split-billing software, resulting in overpurchasing of 340B drugs. Although hypothetical, this scenario illustrates just one of many inventory-related situations

Read More »

Four Drugmakers to Refund 340B Covered Entities for Overcharges

Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024.
Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024, following recalculations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live